Global Disseminated Intravascular Coagulation Diagnosis Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Disseminated Intravascular Coagulation Diagnosis market size was valued at US$ 620 million in 2024 and is forecast to a readjusted size of USD 968 million by 2031 with a CAGR of 6.6% during review period.

Disseminated intravascular coagulation (DIC) is a rare but serious condition that causes abnormal blood clotting throughout the body"s blood vessels. You may develop DIC if you have an infection or injury that affects the body"s normal blood clotting process.DIC is an acquired clinic biological syndrome characterized by widespread coagulation activation, which results in fibrin deposition in the vasculature, organ dysfunction, clotting factor and platelet consumption, and life-threatening hemorrhage. Several underlying disorders can cause disseminated intravascular coagulation (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). The cornerstone therapeutic approaches are treating the underlying disease and eliminating the trigger mechanism. DIC-specific therapeutic strategies aim to reduce blood coagulation activation and bleeding risk. Few clinical trials use DIC as an entry criterion.

Disseminated Intravascular Coagulation (DIC) is a complex medical condition characterized by abnormal blood clotting and excessive bleeding. The diagnosis of DIC involves a combination of clinical assessment, laboratory tests, and the identification of underlying causes. Here are some key insights into the global DIC diagnosis market:

Market Outlook: The global DIC diagnosis market is driven by the increasing prevalence of conditions associated with DIC, such as sepsis and cancer. Additionally, advancements in laboratory diagnostics, growing adoption of POCT devices, and the need for timely diagnosis in critical care settings contribute to market growth. Key players in the global DIC diagnosis market include diagnostic companies, pharmaceutical companies, and medical device manufacturers.

Early and accurate diagnosis of DIC is crucial for timely intervention and management. Healthcare professionals must carefully evaluate clinical symptoms, perform appropriate laboratory tests, and identify the underlying causes to diagnose DIC effectively and develop appropriate treatment strategies.

This report is a detailed and comprehensive analysis for global Disseminated Intravascular Coagulation Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Disseminated Intravascular Coagulation Diagnosis market size and forecasts, in consumption value ($ Million), 2020-2031

Global Disseminated Intravascular Coagulation Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Disseminated Intravascular Coagulation Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Disseminated Intravascular Coagulation Diagnosis market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Disseminated Intravascular Coagulation Diagnosis

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Disseminated Intravascular Coagulation Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, AdvaCare Pharma, Axis-Shield Diagnostics, QuidelOrtho, CTK Biotech, AccuBioTech Co, Getein Biotech, PHC Holdings Corporation, Siemens Healthineers, Eurolyser Diagnostica GmbH, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Disseminated Intravascular Coagulation Diagnosis market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Complete Blood Count with Blood Smear Exam

Partial Thromboplastin Time (PTT)

Prothrombin Time (PT)

Fibrinogen Blood Test

D-dimer Test

Others

Market segment by Application

Hospital

Outpatient Center

Diagnostic and Research Laboratories

Others

Market segment by players, this report covers

Abbott

AdvaCare Pharma

Axis-Shield Diagnostics

QuidelOrtho

CTK Biotech

AccuBioTech Co

Getein Biotech

PHC Holdings Corporation

Siemens Healthineers

Eurolyser Diagnostica GmbH

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Disseminated Intravascular Coagulation Diagnosis product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Disseminated Intravascular Coagulation Diagnosis, with revenue, gross margin, and global market share of Disseminated Intravascular Coagulation Diagnosis from 2020 to 2025.

Chapter 3, the Disseminated Intravascular Coagulation Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Disseminated Intravascular Coagulation Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Disseminated Intravascular Coagulation Diagnosis.

Chapter 13, to describe Disseminated Intravascular Coagulation Diagnosis research findings and conclusion.